SURFACE ONCOLOGY INC's ticker is SURF and the CUSIP is 86877M209. A total of 88 filers reported holding SURFACE ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $21,000 | +31.2% | 24,432 | +7.1% | 0.00% | – |
Q1 2023 | $16,000 | -15.8% | 22,812 | -2.0% | 0.00% | – |
Q4 2022 | $19,000 | -87.5% | 23,285 | -84.1% | 0.00% | – |
Q3 2022 | $152,000 | -30.3% | 146,340 | +10.4% | 0.00% | – |
Q2 2022 | $218,000 | -38.1% | 132,499 | +10.5% | 0.00% | – |
Q1 2022 | $352,000 | -34.0% | 119,929 | +7.7% | 0.00% | – |
Q4 2021 | $533,000 | -35.2% | 111,351 | +2.5% | 0.00% | – |
Q3 2021 | $822,000 | -1.1% | 108,619 | -2.5% | 0.00% | – |
Q2 2021 | $831,000 | +45.5% | 111,459 | +52.3% | 0.00% | – |
Q1 2021 | $571,000 | +45.7% | 73,175 | +72.7% | 0.00% | – |
Q4 2020 | $392,000 | +2700.0% | 42,375 | +2059.8% | 0.00% | – |
Q3 2020 | $14,000 | +366.7% | 1,962 | +330.3% | 0.00% | – |
Q2 2020 | $3,000 | +200.0% | 456 | 0.0% | 0.00% | – |
Q1 2020 | $1,000 | – | 456 | +245.5% | 0.00% | – |
Q4 2019 | $0 | – | 132 | +88.6% | 0.00% | – |
Q4 2018 | $0 | -100.0% | 70 | -84.5% | 0.00% | – |
Q3 2018 | $5,000 | +400.0% | 451 | +880.4% | 0.00% | – |
Q2 2018 | $1,000 | – | 46 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Associates IX, LLC | 2,945,453 | $22,297,000 | 7.41% |
ACT CAPITAL MANAGEMENT, LLC | 170,500 | $1,291,000 | 0.67% |
SummerHaven Investment Management, LLC | 128,078 | $970,000 | 0.57% |
Parkman Healthcare Partners LLC | 248,267 | $1,879,000 | 0.48% |
SILVERARC CAPITAL MANAGEMENT, LLC | 50,000 | $379,000 | 0.21% |
C M BIDWELL & ASSOCIATES LTD | 33,030 | $250,000 | 0.17% |
ARK Investment Management | 4,618,354 | $34,961,000 | 0.08% |
Knights of Columbus Asset Advisors LLC | 114,594 | $867,000 | 0.08% |
Orbimed Advisors | 909,666 | $6,886,000 | 0.08% |
HighVista Strategies LLC | 13,932 | $105,000 | 0.07% |